Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 4/20 | 0.61 |
| ▸ | ITGB3 | P05106 | 3/20 | 0.60 |
| ▸ | ITGA2B | P08514 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | FPR2 | P25090 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 4/20 | 0.49 |
| ▸ | MME | P08473 | 3/20 | 0.49 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29398348 | 1.00 | ACACB (0.61) | ACACBITGB3ITGA2BLMNAFPR2 | |
| SCHEMBL14606874 | 0.90 | ACACB (0.62) | ACACBITGB3ITGA2BLMNAABCB1 | |
| SCHEMBL30658624 | 0.89 | CTSL (0.55) | ACACBITGB3ITGA2BACEMME | |
| SCHEMBL6781722 | 0.87 | FPR2 (0.64) | ACACBITGB3ITGA2BLMNAFPR2 | |
| SCHEMBL4378290 | 0.87 | FPR2 (0.64) | ACACBITGB3ITGA2BLMNAFPR2 | |
| SCHEMBL27569374 | 0.87 | ITGB3 (0.56) | ACACBITGB3ITGA2BFPR2ACE | |
| SCHEMBL27569376 | 0.87 | ITGB3 (0.56) | ACACBITGB3ITGA2BFPR2ACE | |
| SCHEMBL5065823 | 0.86 | ITGB3 (0.67) | ITGB3ITGA2BACEPPARGABCB1 | |
| SCHEMBL1062486 | 0.86 | ITGB3 (0.67) | ITGB3ITGA2BACEPPARGABCB1 | |
| SCHEMBL1311509 | 0.86 | ITGB3 (0.67) | ITGB3ITGA2BACEPPARGABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805476-B | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-112940074-B | Synthesis method of N-acetyl-L-tyrosyl-L-arginine hexadecyl ester | 山东大学 | 2022-09-30 | — | — | CN | claimed |
| CN-114805476-A | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-20240317688-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ZEVRA THERAPEUTICS, INC. | 2024-09-26 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-12012384-B2 | Dextrorphan prodrugs and processes for making and using them | ZEVRA THERAPEUTICS, INC. (US) | 2024-06-18 | — | — | US | disclosed |
| CN-114805476-B | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114805476-B | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-117903238-A | Synthesis process of acetyl dipeptide-1 cetyl ester | 山东济肽生物科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| CN-112940074-B | Synthesis method of N-acetyl-L-tyrosyl-L-arginine hexadecyl ester | 山东大学 | 2022-09-30 | — | — | CN | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| CN-114805476-A | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114805476-A | Preparation method of cetyl ester | 南京莱昂生物科技有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-20220089544-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | ALTER DOMUS (US) LLC | 2022-03-24 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012384-B2 | Dextrorphan prodrugs and processes for making and using them | OGFR, OPRM1, CYP4F3 | ACACB 4302/4885ITGB3 1662/4885ITGA2B 3488/4885 |
| US-12590065-B2 | Levorphanol prodrugs and processes for making and using them | SLC16A3, SLC16A8, SLC16A1 | ACACB 524/4885ITGB3 2453/4885ITGA2B 4098/4885 |
| US-20240317688-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OPRM1, OPRL1, OGFR | ACACB 4568/4885ITGB3 1550/4885ITGA2B 3627/4885 |
| US-20220089544-A1 | DEXTRORPHAN PRODRUGS AND PROCESSES FOR MAKING AND USING THEM | OGFR, OPRM1, CYP4F3 | ACACB 4302/4885ITGB3 1662/4885ITGA2B 3488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.